Abstract: Human insulin analogues having a positively charged amino acid residue, i.e. Lys or Arg, in position B28, further being modified in the C-terminal end of the B-chain from Phe.sup.B24 to the C-terminal amino acid residue and wherein A18, A21 and/or B3 is different from Asn as well as insulin preparations containing the human insulin analogues are provided.
Type:
Grant
Filed:
September 21, 1995
Date of Patent:
February 10, 1998
Assignee:
Novo Nordisk A/S
Inventors:
Per Balschmidt, Jens J.o slashed.rgen Veilgaard Brange